🔗 Permalink

Inventor profile of:

SOFIA MOCO

City:

Lausanne

Country:

Switzerland

Published Applications:

8

Last publication date:

2022-10-13

Top Assignees for applications by SOFIA MOCO

The entities that hold a legal rights for patent applications filed by inventor MOCO SOFIA:

Société des Produits Nestlé S.A. 1 Vevey, Switzerland

Recent patent applications by MOCO SOFIA

SOFIA MOCO from Lausanne, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-13

US20220323468A1

Human necessities

REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE

#2 | 2022-09-22

US20220296623A1

Human necessities

REDUCED NICOTINAMIDERIBOSIDES FOR TREATING OR PREVENTING KIDNEY DISEASE

#3 | 2022-08-25

US20220265625A1

Human necessities

COMPOSITIONS AND METHODS USING TRIGONELLINE AND MINERALS FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE

#4 | 2022-08-11

US20220249462A1

Human necessities

COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NAD+

#5 | 2022-08-11

US20220249453A1

Human necessities

COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR PREVENTING PHYSIOLOGICAL DISORDERS OR STATES

#6 | 2022-08-04

US20220241266A1

Human necessities

COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE

#7 | 2022-08-04

US20220241259A1

Human necessities

COMPOSITIONS AND METHODS USING TRIGONELLINE AND VITAMINS FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE

#8 | 2022-07-28

US20220233565A1

Human necessities

REDUCED NICOTINAMIDERIBOSIDES FOR TREATING/PREVENTING SKELETAL MUSCLE DISEASE

InventorID:

5472477 ⎘